Seeking Alpha

Navidea Biopharmaceuticals (NAVB +4.7%) trades up today after reporting results of its 2013...

Navidea Biopharmaceuticals (NAVB +4.7%) trades up today after reporting results of its 2013 Annual Meeting of Stockholders held earlier today. NAVB made a series of presentations to shareholders highlighting Lymphoseek's U.S commercialization and indication expansion development activities, selection of a specialty pharma partner for its commercialization in Europe, and initiation of a pivotal NAV4694 Phase 3 registration study.
Comments (4)
  • Why is this stock not taking off?
    27 Jun 2013, 08:55 PM Reply Like
  • Patience.
    28 Jun 2013, 10:25 AM Reply Like
  • agree with Joel. $5 before the end of the year.
    1 Jul 2013, 05:53 PM Reply Like
  • Plenty of effort by stronger hands.
    24 Sep 2013, 12:08 AM Reply Like
DJIA (DIA) S&P 500 (SPY)